Scarica l'app Stockscreener
89.07
0.42%
-0.38
Dopo l'orario di chiusura:
89.00
-0.07
-0.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$89.45
Aprire:
$89.41
Volume 24 ore:
1.74M
Relative Volume:
1.06
Capitalizzazione di mercato:
$17.64B
Reddito:
$7.83B
Utile/perdita netta:
$825.20M
Rapporto P/E:
21.69
EPS:
4.1067
Flusso di cassa netto:
$1.05B
1 W Prestazione:
-1.66%
1M Prestazione:
-13.31%
6M Prestazione:
-6.59%
1 anno Prestazione:
-18.49%
Intervallo 1D:
$88.90
$90.51
Intervallo di 1 settimana:
$88.49
$91.28
Portata 52W:
$85.33
$114.44
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
89.07 | 17.73B | 7.83B | 825.20M | 1.05B | 4.1067 |
|
ABT
Abbott Laboratories
|
123.97 | 219.36B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.60 | 143.81B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
360.48 | 139.29B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.35 | 128.70B | 34.76B | 4.79B | 5.30B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
84.09 | 49.92B | 5.88B | 1.34B | 799.60M | 2.3489 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Bragar Eagel & Squire, P.C. Is Investigating Gauzy and Zimmer Biomet and Encourages Investors to Contact the Firm - GlobeNewswire
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zimmer Biomet Holdings, Inc.ZBH - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zimmer Biomet Holdings, Inc.ZBH - PR Newswire
Primecap Management Co. CA Buys 27,860 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Raiffeisen Bank International AG Sells 9,670 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
How big funds are accumulating Zimmer Biomet Holdings Inc. stock2025 Technical Patterns & Entry and Exit Point Strategies - newser.com
Is Zimmer Biomet Holdings Inc. (ZIM) stock positioned for secular growth2025 Price Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
Is Zimmer Biomet Holdings Inc. (ZIM) stock a contrarian opportunity2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com
Why Zimmer Biomet Holdings Inc. stock remains a top recommendation2025 Price Action Summary & Smart Investment Allocation Tips - newser.com
Can Zimmer Biomet Holdings Inc. stock test all time highs2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zimmer Biomet Holdings, Inc. (ZBH) And Encourages Stockholders to Connect - ACCESS Newswire
What margin trends mean for Zimmer Biomet Holdings Inc. stockBull Run & Fast Momentum Entry Tips - newser.com
How robust is Zimmer Biomet Holdings Inc. stock financial positionQuarterly Risk Review & AI Based Buy and Sell Signals - newser.com
What analysts say about Zimmer Biomet Holdings Inc stockEarnings Volatility Patterns & Small Investment Capital Gains - earlytimes.in
Securities Fraud Investigation Into Zimmer Biomet Holdings, - GlobeNewswire
Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders ... - Bakersfield.com
Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman - GlobeNewswire Inc.
Why Zimmer Biomet Holdings Inc. (ZIM) stock is favored by hedge fundsNew Guidance & Reliable Price Breakout Alerts - newser.com
Will Zimmer Biomet Holdings Inc. stock benefit from infrastructure billDollar Strength & AI Powered Market Entry Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Zimmer Biomet Holdings, Inc. (ZBH) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Should I buy Zimmer Biomet Holdings Inc. stock before earnings season2025 Key Highlights & Safe Entry Zone Tips - newser.com
Knee Replacement Surgery Market Analysis Report 2025-2035: Stryker, Zimmer Biomet, B. Braun, and DePuy Synthes Lead Innovations by Continually Innovating and Improving Patient Outcomes - Yahoo Finance
Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by SG Americas Securities LLC - MarketBeat
How Zimmer Biomet Holdings Inc. stock performs in easing cyclesQuarterly Trade Review & Weekly Market Pulse Updates - newser.com
Arnold Schwarzenegger Speaking About His New Role As Chief Movement Officer At Zimmer Biomet [777ea0] - Universitat de Barcelona
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Buys 2,997 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Why Zimmer Biomet Holdings Inc. stock benefits from AI revolutionLong Setup & Accurate Buy Signal Alerts - newser.com
How risky is Zimmer Biomet Holdings Inc. stock now2025 Historical Comparison & Risk Adjusted Buy and Sell Alerts - newser.com
Can Zimmer Biomet Holdings Inc. (ZIM) stock sustain free cash flowJuly 2025 Pullbacks & Long-Term Growth Plans - newser.com
Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zimmer Biomet Holdings, Inc. (ZBH) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Zimmer Biomet gets FDA clearance for enhanced knee replacement system - Inside INdiana Business
Transcript : Zimmer Biomet Holdings, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 12 - MarketScreener
Zimmer Biomet at Jefferies Conference: Strategic Insights and Challenges By Investing.com - Investing.com Canada
Zimmer Biomet at Jefferies Conference: Strategic Insights and Challenges - Investing.com
Candriam S.C.A. Has $1.21 Million Stock Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet’s SWOT analysis: stock faces headwinds amid strategic acquisitions - Investing.com India
Lost Money on Zimmer Biomet Holdings, Inc. (ZBH)? Contact Levi & Korsinsky About Fraud Investigation - ACCESS Newswire
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Zimmer Biomet Holdings Inc Azioni (ZBH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Yi Sang | Group President, Asia Pacific |
Sep 11 '25 |
Sale |
103.58 |
1,200 |
124,302 |
18,584 |
9.66%
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):